Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T Cells Are Highly Permissive to HIV-1 Infection
Overview
Authors
Affiliations
There is limited knowledge on the identity of primary CD4(+) T cell subsets selectively targeted by HIV-1 in vivo. In this study, we established a link between HIV permissiveness, phenotype/homing potential, and lineage commitment in primary CD4(+) T cells. CCR4(+)CCR6(+), CCR4(+)CCR6(-), CXCR3(+)CCR6(+), and CXCR3(+)CCR6(-) T cells expressed cytokines and transcription factors specific for Th17, Th2, Th1Th17, and Th1 lineages, respectively. CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells expressed the HIV coreceptors CCR5 and CXCR4 and were permissive to R5 and X4 HIV replication. CCR4(+)CCR6(-) T cells expressed CXCR4 but not CCR5 and were permissive to X4 HIV only. CXCR3(+)CCR6(-) T cells expressed CCR5 and CXCR4 but were relatively resistant to R5 and X4 HIV in vitro. Total CCR6(+) T cells compared with CCR6(-) T cells harbored higher levels of integrated HIV DNA in treatment-naive HIV-infected subjects. The frequency of total CCR6(+) T cells and those of CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells were diminished in chronically infected HIV-positive subjects, despite viral-suppressive therapy. A high-throughput analysis of cytokine profiles identified CXCR3(+)CCR6(+) T cells as a major source of TNF-alpha and CCL20 and demonstrated a decreased TNF-alpha/IL-10 ratio in CXCR3(+)CCR6(-) T cells. Finally, CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells exhibited gut- and lymph node-homing potential. Thus, we identified CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells as highly permissive to HIV replication, with potential to infiltrate and recruit more CCR6(+) T cells into anatomic sites of viral replication. It is necessary that new therapeutic strategies against HIV interfere with viral replication/persistence in discrete CCR6(+) T cell subsets.
Satija N, Patel F, Schmidt G, Doanman D, Kapoor M, La Porte A Nat Commun. 2025; 16(1):2233.
PMID: 40044684 PMC: 11883074. DOI: 10.1038/s41467-025-57368-7.
Tompa A, Johansson J, Islander U, Faresjo M Biomedicines. 2024; 12(10).
PMID: 39457632 PMC: 11505181. DOI: 10.3390/biomedicines12102319.
Yero A, Goulet J, Shi T, Costiniuk C, Routy J, Tremblay C EBioMedicine. 2024; 107:105274.
PMID: 39178742 PMC: 11388266. DOI: 10.1016/j.ebiom.2024.105274.
The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.
Tolomeo M, Cascio A Int J Mol Sci. 2024; 25(14).
PMID: 39062756 PMC: 11276885. DOI: 10.3390/ijms25147512.
Verma K, Croft W, Margielewska-Davies S, Pearce H, Stephens C, Diaconescu D Blood Adv. 2024; 8(18):4900-4912.
PMID: 39028952 PMC: 11421336. DOI: 10.1182/bloodadvances.2024012909.